Prostate-specific antigen in amniotic fluid of normal and abnormal pregnancies

Clinical Biochemistry

Volumn 29, Issue 6, 1996, Pages 555-562

  Melegos, Dimitrios N ^b   Yu, He ^b   Allen, Lynn C ^b   Diamandis, Eleftherios P ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b NONE

Author keywords

amniotic fluid; fetal abnormalities; fetal development; growth factor regulator; prostate specific antigen; serum constituents

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AMNIOCENTESIS; AMNION FLUID; ARTICLE; FEMALE; FETUS; FETUS DISEASE; FETUS GROWTH; GESTATIONAL AGE; GROWTH REGULATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MATERNAL SERUM; PREGNANCY COMPLICATION; PRIORITY JOURNAL;

EID: 0030561269     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-9120(96)00093-8     Document Type: Article

References (22)

1. 1. Lilja H. A kallikrein-like protease in prostatic fluid cleaves the predominant seminal vesicle protein. J Clin Invest 1985; 76: 1899-903.
2. 2. Armbruster DA. Prostate-specific antigen: biochemistry, analytical methods, and clinical application [Review]. Clin Chem 1993; 39: 181-95.
3. 3. Diamandis EP, Yu H, Sutherland DJA. Detection of prostate specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994; 32: 291-300.
4. 4. Yu H, Diamandis EP, Zarghami N, Grass L. Induction of prostate specific antigen production by steroids and tamoxifen in breast cancer cell lines. Breast Cancer Res Treat 1994; 32: 301-10.
5. 5. Yu H, Diamandis EP, Monne M, Croce CM. Oral contraceptive-induced expression of prostate specific antigen in the female breast. J Biol Chem 1995; 270: 6615-8.
6. 6. Yu H, Diamandis EP, Sutherland DJA. Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994; 27: 75-9.
7. 7. Ashwood ER. Clinical Chemistry of pregnancy. In: Burtis CA, Ashwood ER, Eds. Tietz Textbook of Clinical Chemistry. 2nd Ed. Pp. 2107-48. Philadelphia, WP Saunders, 1994.
8. 8. Yu H, Diamandis EP. Prostate specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995; 41: 204-10.
9. 9. Yu H, Diamandis EP. The serine protease prostate specific antigen is present in the milk of lactating women. Clin Chem 1995; 41: 54-60.
10. 10. Clements J, Mukhtar A. Glandular kallikrein and prostate-specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 1994; 78: 1536-1539.
11. 11. Yu H, Diamandis EP. Ultrasensitive time-resolved immuno-fluorometric assay of prostate specific antigen in serum and preliminary clinical studies. Clin Chem 1993; 39: 2108-14.
12. 12. Oesterling JE. Prostate specific antigen: A critical assessment of the most useful tumor marker for adenocarcimoma of the prostate [Review]. J Urol 1991; 145: 907-23.
13. 13. Moreno JG, Croce CM, Fischer R, Monne M, Vihko S, Mulholland SG, Gomella LG. Detection of hemetogenous micrometastasis in patients with prostate cancer. Cancer Res 1992; 52: 6110-12.
14. 14. Van Krieken JH. Prostate marker immunoreactivity in salivary gland neoplasms. Am J Surg Pathol 1993; 17: 410-4.
15. 15. Knuppel RA, Goodlin RC. Maternal-placental-fetal unit; fetal & early neonatal physiology. In: Pernoll ML, Ed. Current Obstetric & Gynecologic, Diagnosis & Treatment. 7th ed. Pp. 151-78. California, Appleton & Lange, 1991.
16. 16. Varner MW. Disproportionate Fetal Growth. In: Pernoll ML, Ed. Current Obstetric & Gynecologic, Diagnosis & Treatment. 7th Ed, Pp. 340-51. California, Appleton & Lange, 1991.
17. 17. Watt KWK, Lee PJ, M'Timkulu T, Chan WP, Loor R. Human prostate specific antigen: Structural and functional similarity with serine proteases. Proc Natl Acad Sci USA 1986; 83: 3166-70.
18. 18. Cohen P, Graves HCB, Peehl DM, Kamarei M, Giudice LC, Rosenfeld RG. Prostate-specific antigen (PSA) is an insulin-like growth factor binding protein-3 protease found in seminal plasma. J Clin Endocrinol Metab 1992; 75: 1046-53.
19. 19. Kanety H, Madjar Y, Dagan Y, Levi J, Papa MZ, Pariente C, et al. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased in IGFBP-3 is decreased in patients with prostate cancer: correlation with serum prostate-specific antigen. J Clin Endocrinol Metab 1993; 77: 229-33.
20. 20. Killian CS, Corral DA, Kawinski E, Constantine RI. Mitogenic response of osteoblast cells to prostate-specific antigen suggests an activation of latent TGF-b and a proteolytic modulation of cell adhesion receptors. Biochem Biophys Res Commun 1993; 192: 940-7.
21. 21. Espana F, Gilabert J, Estelles A, Romeu A, Asnar J, Cabo A. Functionally active protein C inhibitor/plasminogen activator inhibitor-3 (PCI/PAI-3) is secreated in seminal vesicles, occurs at high concentrations in human seminal plasma and complexes with prostate-specific antigen. Thrombosis Res 1991; 64: 309-20.
22. 22. Cross JC, Werb Z, Fisher SJ. Implantation and the placenta: Key pieces of the developmental puzzle [Review]. Science 1994; 266: 1508-18.